As of 2026-04-01, 重组全人源抗狂犬病毒单抗's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 2 competitors in the same category, 重组全人源抗狂犬病毒单抗's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
重组全人源抗狂犬病毒单抗's Mention Rate is 0.00%, lower than 0.6% of competitors
重组全人源抗狂犬病毒单抗's First Mention is 0.00%, lower than 0.9% of competitors
重组全人源抗狂犬病毒单抗's Preferred Rate is 0.00%, lower than 100.0% of competitors
重组全人源抗狂犬病毒单抗's Positive Rate is 0.00%, lower than 8.9% of competitors
重组全人源抗狂犬病毒单抗's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| FFarxiga（达格列净） | 0% | 0% | 0% | 0% | 0% | View Details |
| TTagrisso（奥希替尼） | 0% | 0% | 0% | 0% | 0% | View Details |
| 重重组全人源抗狂犬病毒单抗 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
